-
Paychex Faces Growth Gap: Can It Deliver On 2026 Targets?
Thursday, June 26, 2025 - 11:00am | 298Read More...The primary challenge in Paychex Inc.'s (NASDAQ:PAYX) latest results and guidance is reconciling the fiscal fourth quarter's 3% year-on-year organic revenue growth with the 5% guidance for fiscal 2026, according to Stifel. The Paychex Analyst: Analyst David Grossman maintained a Hold rating, while...
-
IBM Posts Q4 Earnings Beat, Shifts Focus To Software As Analysts Raise Forecasts
Thursday, January 30, 2025 - 11:30am | 523Read More...Shares of IBM (NYSE:IBM) were climbing in early trading on Thursday, after the company reported upbeat fourth-quarter results. The company reported its quarterly results amid an exciting earnings season. Here are some key analyst takeaways. Goldman Sachs On IBM Analyst James Schneider maintained a...
-
IBM's AI Bookings To Drive Share Gains, Though 'Revenue Contribution Of AI Is Currently Small'
Thursday, July 25, 2024 - 12:19pm | 602Read More...IBM (NYSE:IBM) shares were climbing in early trading on Thursday after the company reported its second-quarter results. The results came amid an exciting earnings season. Here are some key analyst takeaways. Goldman Sachs On IBM Analyst James Schneider reiterated a Buy rating while raising the...
-
Teladoc Health Delivers Mixed Results, 'Sobering' Guidance: 6 Analysts Provide Key Takeaways
Wednesday, February 21, 2024 - 1:44pm | 704Read More...Shares of Teladoc Health Inc (NYSE: TDOC) tanked in early trading on Wednesday, after the company misses revenue expectations for the fourth quarter and issued weak first-quarter guidance. The results came amid an exciting earnings season. Here are some key analyst takeaways from the release. RBC...
-
IBM's Q4 Results Showcase Revenue Growth: 4 Analysts Take A Closer Look
Thursday, January 25, 2024 - 1:44pm | 539Read More...Shares of IBM (NYSE: IBM) climbed in early trading on Thursday, after the company reported stronger-than-expected results for its fourth quarter. The results came amid an exciting earnings season. Here are some key analyst takeaways from the release. BMO Capital Markets On IBM Analyst Keith Bachman...
-
Teladoc Health Analysts Give Mixed Prognosis Following Q4 Earnings
Wednesday, February 23, 2022 - 1:25pm | 566Read More...Shares of Teladoc Health, Inc. (NYSE: TDOC) shares are lower after the telemedicine company issued below-consensus guidance for the first quarter. The Teladoc Analysts: Needham analyst Ryan MacDonald reiterated a Buy rating on Teladoc shares and reduced the price target from $170 to $100....
-
Cannabis Movers & Shakers: Marijuana Co. Of America, Akerna, Seedo, PSYC, Aurora
Tuesday, July 7, 2020 - 1:45pm | 1993Read More...Another Tuesday has come with a new list of leadership changes that shook up the cannabis industry over the past week. Marijuana Company Of America (MCOA) Names Tim Psomiadis VP Of M&A Themistocles (Tim) Psomiadis has been named executive vice president of mergers and acquisitions at...
-
Analysts React To IBM's Q2; Report 'Helps Put In A Valuation Floor,' Says Morgan Stanley
Thursday, July 19, 2018 - 2:40pm | 491Read More...IBM (NYSE: IBM) reported second-quarter earnings Wednesday, narrowly beating consensus estimates for both EPS and sales. Investors responded positively for the most part, though some commentators did express concerns about the details. The Analysts Morgan Stanley’s Katy Huberty...
-
IBM Selling Off After Q1 Print: 5 Analysts Respond
Wednesday, April 18, 2018 - 2:45pm | 528Read More...IBM Common Stock (NYSE: IBM) traded lower by 7.5 percent on Wednesday and is on pace for its worst day of trading since 2013. Investors were disappointed with IBM’s sluggish growth numbers and could be throwing in the towel on the tech stock. Several analysts have weighed in on the...
-
Analyst: Investor's Negative Reaction To Paychex Guidance May Be Overdone
Tuesday, March 27, 2018 - 4:25pm | 353Read More...Paychex, Inc. (NASDAQ: PAYX) reported its fiscal third quarter earnings report Monday which included a revenue beat and in-line earnings but the company's full year guidance may have disappointed some investors -- "unnecessarily" so, according to Stifel. The Analyst Stifel'...
-
Stifel Cuts Target On IBM $20, Believes Lowered Outlook Signals 'Weak' Q3 Exit Rate
Tuesday, October 20, 2015 - 10:31am | 363Read More...International Business Machines Corp. (NYSE: IBM) shares are down 12 percent year-to-date, having plummeted from above $170 on July 20 to below $141 on August 25. Stifel’s David Grossman maintained a Buy rating on the company, while reducing the price target from $180 to $160. The...
-
Stifel Downgrades Computer Sciences Amid M&A Rumors
Tuesday, February 24, 2015 - 11:54am | 184Read More...In a report issued on Tuesday, Stifel downgraded Computer Sciences Corporation (NYSE: CSC) to Hold after an M&A trade publication reported that the company was in discussions to sell its commercial and government units to a strategic and financial buyer. Analysts David Grossman and Irvin...
-
Stifel Lowers IBM's 2015 Earnings Estimates
Monday, January 12, 2015 - 9:00am | 252Read More...David Grossman of Stifel on Monday maintained a Buy rating on International Business Machines Corp. (NYSE: IBM) despite lowering the company's 2015 earnings per share estimates to $15.17 from a previous $16.00 estimate. Grossman notes there are four factors affecting IBM's Software...
-
UPDATE: Stifel Downgrades Automatic Data Processing As Risk/Reward Comes Into Balance
Friday, December 5, 2014 - 10:36am | 131Read More...In a report published Friday, Stifel analyst David Grossman downgraded the rating on Automatic Data Processing (NASDAQ: ADP) from Buy to Hold, and removed the $83.00 price target. In the report, Stifel noted, “We are downgrading ADP from Buy to Hold and removing it from the Income Opportunity Ideas...
-
UPDATE: Stifel Downgrades Sapient To Reflect Publicis Acquisition
Thursday, November 20, 2014 - 10:25am | 138Read More...In a report published Thursday, Stifel analyst David Grossman downgraded the rating on Sapient Corporation (NASDAQ: SAPE) from Buy to Hold, and removed the $19.50 price target. In the report, Stifel noted, “We are downgrading SAPE to Hold to reflect the company's acquisition by French advertising...
